UNSPSC 41181564: Transferrin immunological test system

In this classification, a Transferrin immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Transferrin. US FDA regulates Transferrin immunological test system under 21 CFR 866.5880 and under FDA product code JNM.

UNSPSC 41181564 Transferrin immunological test system is a Commodity code. State and local government procurement under this code shows minimal relevant recent activity. The source material contains seventeen recent opportunities posted between May and October 2026 across state agencies, county governments, cities, universities, and transit authorities in Florida, Texas, Colorado, Oregon, and other jurisdictions; however, only one opportunity—Marion County, Oregon's laboratory testing services and phlebotomy solicitation (ITB SO1814-26, due July 24, 2026)—touches laboratory testing broadly. That solicitation seeks specimen collection supplies, courier services, test reporting, and phlebotomist services for adults in custody; it does not specifically name transferrin immunological testing or related serology work. The remaining sixteen opportunities address optical surface profilometry, airfield lighting photometry, drug discovery software licenses, electric meter test boards, high-voltage capacitance measurement modules, water quality analyzers, brake testers, nanoindentation systems, atmospheric monitoring instruments, oil testing laboratory services, landscape architectural services, and spectrophotometry—none of which align with immunological testing, transferrin assays, or related diagnostic serology.

The mismatch between the code's nominal scope and posted opportunities suggests that transferrin immunological test system procurement either does not occur frequently enough to surface in recent state and local notices, or when such testing is procured, it is typically embedded within broader laboratory services agreements or clinical service contracts tagged with different UNSPSC codes. No issuing body has posted a dedicated solicitation for transferrin test kits, reagents, or immunoassay platforms in the timeframe represented. Firms targeting this code should monitor ongoing laboratory service RFPs from state health departments, county health authorities, and university medical research programs, but should not expect dedicated commodity-level transferrin testing solicitations to be common or near-term.